Our results confirmed that PIK3CA mutation increased APOA5 expression and facilitated PPARγ signaling activation to inhibit ROS production in CRC cells, leading to decreased cell apoptosis of L-OHP-treated cells. This evidence concerns the gene PIK3CA and colorectal carcinoma.